The Lancet Gastroenterology & Hepatology in conversation with
Statins and decompensated cirrhosis
November 27, 2019
The Lancet
Statins and decompensated cirrhosis
The Lancet Gastroenterology & Hepatology in conversation with
More Info
Share
The Lancet Gastroenterology & Hepatology in conversation with
Statins and decompensated cirrhosis
Nov 27, 2019
The Lancet
Dr. Elisa Pose discusses the potential beneficial effects of statins on the treatment of patients with decompensated cirrhosis
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Dr. Elisa Pose discusses the potential beneficial effects of statins on the treatment of patients with decompensated cirrhosis
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv